Israel’s Wilk, a publicly-traded company on the Tel Aviv Stock Exchange under the ticker symbol WILK, develops industrial processes for producing cultivated human and animal milk from milk-producing mammary cells. The company announces it has now received US patent approval. “This will help to further establish our reputation as a leader in the field of cell-based milk […]
